Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Drug targeting of NR4A nuclear receptors for treatment of acute myeloid leukemia.

Boudreaux SP, Duren RP, Call SG, Nguyen L, Freire PR, Narayanan P, Redell MS, Conneely OM.

Leukemia. 2019 Jan;33(1):52-63. doi: 10.1038/s41375-018-0174-1. Epub 2018 Jun 8.

2.

Genome Wide Mapping of NR4A Binding Reveals Cooperativity with ETS Factors to Promote Epigenetic Activation of Distal Enhancers in Acute Myeloid Leukemia Cells.

Duren RP, Boudreaux SP, Conneely OM.

PLoS One. 2016 Mar 3;11(3):e0150450. doi: 10.1371/journal.pone.0150450. eCollection 2016.

3.

Genome-wide profiling reveals transcriptional repression of MYC as a core component of NR4A tumor suppression in acute myeloid leukemia.

Boudreaux SP, Ramirez-Herrick AM, Duren RP, Conneely OM.

Oncogenesis. 2012 Jul 2;1:e19. doi: 10.1038/oncsis.2012.19.

Supplemental Content

Loading ...
Support Center